Dr. Alistair Lindsay appointed to lead Healthcare Strategy Division

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2012/08/AL2.png” align=”left” ]

LONDON, United Kingdom, 05 January, 2014: Regent’s Park Heart Clinics (Regent’s Park), an independent company specialising in the provision of cardiology services, today announced it has appointed Dr. Alistair Lindsay to leads its Healthcare Strategy Division.

Dr. Alistair Lindsay is a cardiologist at the Royal Brompton Hospital, London, UK.  He will lead a team of strategy consultants that provide our NHS and industry clients with innovative solutions based on deep sector insight, analytical rigor, and an objective perspective.

Alistair joined the Royal Brompton in 2010 from Oxford where he was the John Radcliffe Hospital Cardiovascular Fellow. His main interest is the use of both invasive and non-invasive techniques to diagnose heart problems and to guide treatment.  In particular he has experience in the use of magnetic resonance imaging (MRI), computed tomography (CT), intravascular ultrasound (IVUS) and optical coherence tomography (OCT).  He has published widely and participated in both local and international studies on the diagnosis and treatment of atherosclerosis. Dr. Lindsay currently serves on the editorial board of the cardiovascular journal Heart, for which he serves as the digital media editor and contributes to the journal’s blog.

Alistair holds degrees in Molecular Biology and Medicine from the University of Edinburgh, a DPhil from the University of Oxford, and an MBA from London Business School. In 2010 he was named “Young Trainee of the Year” by the Royal Society of Medicine.

Dr. Ohri, Chief Executive of Regent’s Park said: “I am absolutely delighted that Dr. Lindsay has accepted the offer of my board to lead our Healthcare Strategy Division.” He added: “Experience is crucial, and Alistair certainly has a veritable set of experiences having operated at the intersection of clinical practice, science, operations management and business strategy over many years.”

Regent’s Park has been a national provider of cardiology services to the NHS since 2003. The company comprises five operating divisions arranged across a nationwide network of cardiac catheterisation laboratories, cardiac personnel and specialist heart clinics that together have delivered over 85,000 invasive cardiology procedures – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator insertions and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park awarded managed invasive cardiology services contract in Northern Ireland

[frame src=https://www.rphc.co.uk/wp-content/uploads/2013/10/Craigavon-Area-Hospital1.jpg width=”180″ height=”120″ lightbox=”on” title=”Regent’s Park awarded managed invasive cardiology services contract at Craigavon in Northern Ireland” align=”left” ]

LONDON, United Kingdom, 20 October, 2013: Regent’s Park Cardiovascular Solutions Ltd. (Regent’s Park), an independent healthcare company specialising in the provision of cardiology services to the NHS, today announced it has been awarded a major contract to provide managed cardiology services to Craigavon Area Hospital, part of the Southern Health and Social Care Trust in Northern Ireland.

Dr. Ohri, Chief Executive Officer of Regent’s Park said: “We are delighted to have won this highly competitive tender and to break into a brand new territory of the United Kingdom.” He added: “The contract provides the Trust with additional capacity and outsources the management of percutaneous coronary intervention (PCI), angiography and pacemaker services into a brand new cath lab which we will supply and fully staff.” He commented: “The Trust needed a cardiology partner with the resources, expertise and track-record of delivering complex cardiology services. The tender was advertised in the Official Journal of the European Union and we were especially pleased to receive near perfect 100% evaluation scores across the criteria of quality, finance and deliverability.”

Dr. Ohri said: “Developing innovative services and solutions that create efficiencies, address costs and improve patient access and outcomes has been a core component of our operating model since 2003. We expect these same core value propositions will be increasingly relevant as the NHS cardiology marketplace becomes ever more focused on cost efficiency and service quality over the next ten years.”

The Southern Health and Social Care Trust is a major provider of acute hospital and social care services across the five council areas of Armagh, Banbridge, Craigavon, Dungannon, and Newry and Mourne. The Trust employs approximately 13,000 staff and spends £532 million annually in the delivery of health and social care services. Craigavon Area Hospital has an established invasive cardiology department that performs a full range of cardiology interventions including primary PCI and electrophysiology & ablation. According to the latest British Cardiovascular Intervention Society audit, Northern Ireland has one of the highest intervention rates for percutaneous coronary interventions in the United Kingdom at 1917 per million of the population.

Regent’s Park has been a national provider of cardiology services to the NHS since 2003. The company comprises five operating divisions arranged across a nationwide network of cardiac catheterisation laboratories, cardiac personnel and specialist heart clinics that together have delivered over 85,000 invasive cardiology procedures – coronary angiograms, angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator insertions and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park nominated to receive a 2013 European Business Award

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2013/07/EBA-2013.jpg” width=”180″ height=”120″ lightbox=”on” title=”Regent’s Park nominated to receive a 2013 European Business Awards” align=”left” ]

LONDON, United Kingdom, 28 July, 2013: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced that it has been nominated to win a prestigious 2013 European Business Award in the category of ‘Customer Focus’ by RSM Tenon, a leading accountancy and advisory firm.

Since 2007, the European Business Awards (EBAs) have been shining a light on the most innovative businesses on the continent by promoting success, innovation and ethics in the European business community. In 2012, the EBAs engaged with over 15,000 organisations in over 30 countries showcasing the best in class, the winners from a diverse range of industries including cosmetics, engineering, fashion, online businesses, manufacturing and transport were congratulated by an audience comprising heads of state, leading industrialists, entrepreneurs, business leaders, media owners and academics from across 30 European nations. Participants represented a combined turnover of over €1 trillion Euros (8.23% of EU GDP)*, employing over 2.7 million people.

The citation in the award category for customer focus reads: “An important aspect of business development, customer focus ensures that services provided are useful and relevant to current and potential customers. As a core practice it drives growth through a deep understanding of customer values. This award celebrates organisations that have enhanced their prospects by putting the customer at the heart of its business.” See more details on the awards here: http://www.businessawardseurope.com/

Regent’s Park has been a national provider of cardiology services to the NHS since 2003. The company comprises five operating divisions arranged across a nationwide network of cardiac catheterisation laboratories, cardiac personnel and specialist heart clinics that together have delivered over 75,000 invasive cardiology procedures – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator insertions and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Cambridge Heart Clinic celebrates top marks in Quality & Safety of Care Inspection

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2013/05/CQC-new_logo_CMYK1.jpg” width=”180″ height=”120″ lightbox=”on” title=”Cambridge Heart Clinic celebrates top marks in Quality & Safety of Care Inspection” align=”left” ]

Cambridge, United Kingdom, 29 May, 2013: Staff at the Cambridge Heart Clinic, a subsidiary of Regent’s Park, are celebrating after they received top marks in its latest inspection by the Care Quality Commission (CQC), the government body responsible for maintaining quality and safety standards across private and NHS healthcare facilities.

The CQC inspectors reported that the quality and safety of care delivered to patients at the Cambridge Heart Clinic met the standards in all areas examined. They reported that patients are properly consented to care and treatment, cared for safely and that the clinic provided a clean and safe environment.

The CQC carried out their unannounced visit on 26 April 2013. They looked at the personal care and treatment records of people who used our services, and checked how our patients were cared for as well as talking with patients who used our services.

The CQC inspectors spoke with a large cohort of people who had received treatment. They reported that each patient made positive comments about the quality of the service. One person said, “Nothing was too much trouble for them. They were excellent in every way”. Another person said, “They were brilliant, everything was impeccable”.

Sheena Fisher, Practice Manager at the Cambridge Heart Clinic said: “I am delighted that the hard work of the clinic team has been independently recognised in this report and that our patients are happy. I am looking forward to further developing the quality of our service and providing the best possible care, based on the highest professional standards at all times.”

Dr. Ohri, Chief Executive at the Cambridge Heart Clinic said: “The CQC gave us a thorough and unannounced inspection and we are very pleased with the results.  We aim to set the pace and be a leader in cardiology services and the Commission has acknowledged the efforts we are making to be a patient-centric organisation.  There is always more work to do, of course, and we are already aiming to exceed these high standards, but our dedicated operations and clinical staff should feel proud to achieve such positive feedback.”

The full CQC report can be found on their website here: http://www.cqc.org.uk/directory/1-120823913

The Cambridge Heart Clinic is a partnership between Cambridge University Hospitals NHS Foundation Trust and Regent’s Park Heart Clinics Ltd. that has been operating since 2008.  For more information visit: www.cambridgeheartclinic.co.uk

Regent’s Park has been a national provider of cardiology services to the NHS since 2003. The company comprises five operating divisions arranged across a nationwide network of cardiac catheterisation laboratories, cardiac personnel and specialist heart clinics that together have delivered over 75,000 invasive cardiology procedures – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator insertions and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Download a PDF of this article here.

Regent’s Park shortlisted to provide managed invasive cardiology services at Imperial College Healthcare NHS Trust

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2013/03/Imperial2.jpg” width=”180″ height=”120″ lightbox=”on” title=”Regent’s Park shortlisted to provide managed invasive cardiology services at Imperial College Healthcare NHS Trust” align=”left” ]

LONDON, United Kingdom, 8 March, 2013: Regent’s Park Heart Clinics (Regent’s Park), an independent company specialising in the provision of cardiology services, today announced it has been shortlisted to the final bidding stage to provide managed invasive cardiology services at Imperial College Healthcare NHS Trust.

The tender was advertised in the Official Journal of the European Union (OJEU reference 2012/S 224-369274) in December 2012 and invited bidders to provide a full range of managed cardiology services across the Hammersmith & St. Mary’s Hospital sites in West London. The successful bidder is expected to provide the capital to procure two new cardiac cath labs and provide managed equipment services for new and legacy equipment across all five cath labs suites. In addition, there is a requirement to manage the procurement and logistics of cath lab consumables (stents, guidewires, catheters, devices and pacemakers) as well as to provide systems and clinical data analytics to benchmark cath lab activity with quality standards.

Dr. Ohri, Chief Executive of Regent’s Park said: “We are very pleased to have passed the rigorous pre-qualification criteria and to have been selected from a long list, we believe around twelve, of initial applicants. We understand we are now down to the last two or three that have been invited to participate in commercial dialogue with the Trust.” He added: “Given our track record and experience, these are clearly the type of managed cardiology service contracts that our company is well suited to manage; we look forward to putting our best foot forward in the weeks ahead for what we know will be a highly competitive last round.”

Regent’s Park has been a national provider of cardiology services to the NHS since 2003. The company comprises five operating divisions arranged across a nationwide network of cardiac catheterisation laboratories, cardiac personnel and specialist heart clinics that together have delivered over 65,000 invasive cardiology procedures – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator insertions and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

One of the world’s largest pharmaceutical companies partners with Regent’s Park Heart Clinics

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2013/01/pills-dna.jpg” width=”180″ height=”120″ lightbox=”on” title=”One of the world’s largest pharmaceutical companies partners with Regent’s Park Heart Clinics” align=”left” ]

LONDON, United Kingdom, 10 January, 2013: Regent’s Park Heart Clinics (Regent’s Park), an independent company specialising in the provision of cardiology services, today announced it has been selected by a global pharmaceutical company with a market capitalisation of over £170 billion to provide clinical diagnostic services in 72 of its centres across the United Kingdom. The partnership has been operating since July 2012 across 10 sites and given its huge success will now be rolled out across 62 more centres in 2013.

Dr. Ohri, Chief Executive of Regent’s Park said: “Given the intense competition in this area of the pharmaceutical industry we are delighted to have passed, and in many areas exceeded, the rigorous quality and safety criteria they set before selecting a service partner.” He added: “The monitoring and clinical evaluation services we provide are led by our teams of cardiac physiologists and consultant cardiologists using a proprietary  realtime tele-diagnostics solution we have developed in-house. This innovative method of data gathering  and reporting means professional opinions on physiological changes to the heart and the potential cardiotoxicity of certain drugs are available instantaneously – rapid, high quality interpretation of clinical data in this type of environment is clearly crucial.”

More information on this exciting partnership will be released later this year.

Regent’s Park receives high praise from the Royal Devon & Exeter NHS Foundation Trust

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2012/11/Cardiology-HD-Magazine-Cover-Nov-Dec-2012.jpg” width=”180″ height=”120″ lightbox=”on” title=”Regent’s Park receives high praise from the Royal Devon & Exeter NHS Foundation Trust” align=”left” ]

LONDON, United Kingdom, 1 November, 2012: Regent’s Park Cardiovascular Solutions Ltd. (Regent’s Park), an independent healthcare company specialising in the provision of cardiovascular solutions to the NHS, today announced it received high praise for its rapid response and efficient completion of a cath lab project at Wonford hospital, part of the Royal Devon & Exeter NHS Foundation Trust.

Bryn Webber, Cardiac Services Director of Regent’s Park said: “We were delighted to have been in a position to provide a novel solution to this Trust in a time of need. The Trust had a major waiting list issue for coronary angiography and required a rapid and affordable solution. The Trust needed an experienced partner capable of delivering a fully staffed, high quality environment within a very rapid timescale, and we were very pleased to be able to meet their expectations. We met with the Trust and by the following day had offered them a bespoke plan. This consisted of using one of our fleet of interim cardiac cath labs and a complement of 4 staff per day over 35 consecutive days. With no service operations in the south west of England we realised there would be staffing challenges. In addition, the Trust required us to perform on average 11 procedures each day or around 400 procedures over the short period and to achieve this level of operational efficiency we knew we would need to call upon some of our most experienced staff from across our field of operations. We provided staff with an average of 12 years cath lab experience, achieving all the objectives we were set and performing close to 400 procedures within budget and on time.”

Dr. Bellenger, Director of Cardiology at Royal Devon & Exeter NHS Foundation Trust said in a letter to the company: “Can I take this opportunity again to thank you and your team of cath lab staff for their enthusiasm and support in delivery of the mobile lab plan. The experience from all the RDE staff has been extremely positive. The service has been run very efficiently and delivered precisely what we wanted it to do for the patients here. So thank you.”

Dr. Ohri, Chief Executive of Regent’s Park, said, “It has been a privilege to work alongside the Royal Devon & Exeter NHS Foundation Trust. We always try to raise the bar for quality at Regent’s Park and I am very proud of our team and service record at Wonford hospital.” He added: “I believe this project has been executed to a very high standard for several reasons – our responsiveness, a strategy of providing high quality cath labs, detailed planning and operations management and most importantly, the professionalism of Regent’s Park staff.”

Dr. Ohri added: “I would like to use this opportunity to pay a special tribute to the following Regent’s Park staff who through their hard work made this partnership so successful:

• Radiographers: Carolyn Howarth, Susan Knight, Tim Larner. • Cardiac Physiologists: Sofia Pereira, Rentia Pienaar, Joana Teixeira, James Weatherby. • Cardiac Nurses: Penny Cantelon, Genalyn Carreon, Ron Ciocson, Pauline Hough, Petula Lemessy, Martha Muchanyuka, Lissa Philip, Diane Scaletta.

For more information on the operational efficiencies achieved across the duration of this project, please read an article featured on the front page of edition 39, Nov-Dec 2012, pages 8-9 of ‘Cardiology HD’  – a leading coronary heart publication.

Regent’s Park has been a national provider of cardiology services to the NHS since 2003. The company comprises five operating divisions arranged across a nationwide network of cardiac catheterisation laboratories, cardiac personnel and specialist heart clinics that together have delivered over 50,000 invasive cardiology procedures – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator insertions and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Regent’s Park pioneers cardiology services at Scarborough Hospital

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2012/03/Cardiology-HD-Magazine-Cover-Sep-Oct-2012.jpg” width=”180″ height=”120″ lightbox=”on” title=”Regent’s Park pioneers cardiology services at Scarborough Hospital” align=”left” ]

Regent’s Park Cardiovascular Solutions Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it has been awarded a ground-breaking contract to provide managed cardiology services at Scarborough Hospital, part of the Scarborough and North East Yorkshire Healthcare NHS Trust.

Bryn Webber, Cardiac Services Director of Regent’s Park said: “We are very pleased to have been awarded this contract using one of our new series of bespoke cath labs.” He added: “As part of this service we are providing a state-of-the-art modular catheter lab with the very latest coronary imaging system, a Siemens Artis Zee, with a full complement of specialist cardiac staff as well as cardiology consumables.”

Dr. Tim Houghton, Lead Consultant Cardiologist at Scarborough Hospital, said: “The launch of this new invasive cardiology service will make a huge impact on our ability to provide high quality, local services to our patients.” He added: “Fundamentally, it will reduce the need of our patients to travel to other cardiology centres such as York, whilst improving the diagnosis and management of coronary heart disease for patients in Scarborough and its surrounding areas.” Dr. Houghton added: “Everyone in our
Trust has been extremely impressed with the professional approach of Regent’s Park and we would have no hesitation in recommending their services to other NHS hospitals looking to expand their cardiology service offering.”

Dr. Ohri, Chief Executive said: “Winning this competitive tender is terrific news for our company. The success helps expand our nationwide distribution network of healthcare services and confirms our position as the UK’s leading managed cardiology services provider.” Dr. Ohri added: “The award is perfectly aligned with our strategy of working with NHS hospitals to meet the challenges for expanding access to invasive cardiology services to local communities.” He commented: “Regent’s Park staff and managers look forward to the privilege of working with the highly professional Trust staff and cardiologists at Scarborough Hospital in the years ahead.”

Scarborough Hospital is a major provider of acute hospital services for around 240,000 people living in and around Scarborough, Bridlington, Whitby and Ryedale. It is also the largest employer in the area employing over 2,400 staff. The hospital already has a well established coronary care unit and cardiology department and this new cardiac catheter laboratory will allow the Trust to now fully manage the diagnosis and treatment of patients with heart disease.

For more information on the Scarborough service, please read an article featured on the front page of edition 38, Sep-Oct 2012, pages 12-14 of ‘Cardiology HD’ – a leading coronary heart publication.

Regent’s Park has been a national provider of cardiology services to the NHS since 2003. The company comprises five operating divisions arranged across a nationwide network of cardiac catheterisation laboratories, cardiac personnel and specialist heart clinics that together have delivered over 40,000 invasive cardiology procedures – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator insertions and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

Dr. Ohri wins the Entrepreneurial Achievement Award at the 2011 Independent Healthcare Awards

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2012/11/IHA_2011_winner.jpg” width=”180″ height=”120″ lightbox=”on” title=”Dr. Ohri wins the Entrepreneurial Achievement Award at the 2011 Independent Healthcare Awards” align=”left” ]

LONDON, United Kingdom, 25 September, 2011: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced that Dr. Anil Ohri, its Founder and Chief Executive, won the 2011 Independent Healthcare Award for ‘Entrepreneurial Achievement’. The Independent Healthcare (IH) awards ceremony took place at a gala dinner attended by over 550 guests from across the United Kingdom independent healthcare sector at the Grosvenor Square Hotel, London on 20th September, 2011.

Entering their sixth year, Laing & Buisson’s IH awards are widely considered to be the most prestigious event in the healthcare sector calendar. The judging panel (see below) aims to highlight the range of achievements within the independent healthcare sector and to pay tribute to those individuals and teams who have demonstrated management leadership, excellence and the spirit of enterprise across the full range of independent health and social care delivery. Laing & Buisson are a leading independent provider of market intelligence to the independent sector and publisher of ‘Healthcare Market News’.

The criteria for the entrepreneurial achievement award category read as follows: To reward those individuals or companies that demonstrate both a flair for, and continuing commitment to, business enhancement through entrepreneurial activity. Nominations should show where such activity has had a demonstrable affect on the growth of a business. The preeminent entrepreneur will express the drive, vision, creativity, managerial acumen and leadership traits that make him/her successful business men/women. Nominees must be able to demonstrate: the spirit to create a successful business through perseverance and by using their own visionary efforts. The award was sponsored by Oliver Wyman, a leading global management consulting firm, and presented to Dr. Ohri by Gyles Brandreth the writer, broadcaster, former MP and Lord Commissioner of the Treasury.

In response to the award, Dr. Ohri said: “I would like to thank the judging panel for this hugely prestigious award which I will always cherish. I never dreamt back in 2002 when I started my company that I could be standing here today. It has been a fascinating journey and I know there is still so much more to do. It feels especially significant receiving this award from senior judges within your own peer group – I would like to believe it is a strong endorsement of our business model and operations to date. I want to thank all the many people who are responsible – the people who’ve organized this event tonight, and the people, some are here, some not, who’ve helped me along my business journey and inspired me to reach out for the stars.” He added: “Perhaps I can focus on just three groups of them. My family who have never left my side and keep me grounded. My teachers at the London Business School who taught me the very best disciplines of business, and lastly my management team who help to move theory and dreams into practical execution.”

Judging Panel for the Award:

• William Laing: Chief Executive, Laing & Buisson • Lord Carter of Coles: Chairman, Cooperation & Competition Commission • Sir Peter Gershon: Chairman, General Healthcare Group • Nick Bosanquet: Professor of Health Policy, Imperial College London • Bob Rickets: Director of Provider Policy, Department of Health • Jocelyn Ormond: Head of Private Sector Healthcare, Beachcroft • Martin George: Managing Director, Group Development, BUPA Cromwell Hospital • Dr. Jean-Jacques: Clinical Services Director, Spire Healthcare • Dr. Andy Jones: Medical Director, Nuffield Health • Tim Pearl: Development Director, Ramsay Health • Dr. Rory McCrea: Chairman, ChilversMcCrea Healthcare • Justin Merritt: Creative Director, Laing & Buisson • Paul Birley: Head of Healthcare, Barclays • Sally Taber: Chief Executive, Independent Advisory Service • Ingrid Smilie: Strategic Director, Community Integrated Care • Henry Elphick: Managing Director, Jefferies International • John Roger: Chief Executive, Skills for Health • Matt James: Chief Executive, Private Hospitals Alliance

Regent’s Park also won the runner-up prize in the ‘Innovation’ category.

Regent’s Park has been a national provider of cardiology services to the NHS since 2003. The company comprises five operating divisions arranged across a nationwide network of cardiac catheterisation laboratories, cardiac personnel and specialist heart clinics that together have delivered over 35,000 invasive cardiology procedures – coronary angiograms, coronary angioplasty, cardiac electrophysiology, transcatheter aortic valve implantations, defibrillator insertions and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff and uncompromising professionalism.

Regent’s Park invited to speak alongside the Cleveland Clinic on innovation in healthcare delivery

[frame src=”https://www.rphc.co.uk/wp-content/uploads/2012/11/cleveland_clinic.jpg” width=”180″ height=”120″ lightbox=”on” title=”Regent’s Park invited to speak alongside the Cleveland Clinic on innovation in healthcare delivery” align=”left” ]

LONDON, United Kingdom, 14 July, 2011: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced that its Chief Executive, Dr. Ohri, has been invited to speak at the 2011 Deloitte Institue of Innovation and Entrepreneurship conference at the London Business School.

This one-day meeting is designed to stimulate peer-to-peer discussion between senior executives within the healthcare provider system, to explore the range of innovations that can be made in healthcare delivery and to learn from those who have successfully led these changes.

The keynote speaker this year is Dr. Martin Harris, Chief Information Officer, Cleveland Clinic, USA

Below is an excerpt of the background to the meeting: “This meeting comes at a time when the healthcare system is facing huge funding challenges. innovation in delivery will be a major component in reducing costs and improving outcomes. However, the challenges are immense for healthcare leaders who must identify, prioritise and drive these innovations. Innovation in delivery is more complex than product innovation precisely because it requires change from within with all the concomitant technical, political and cultural challenges. The symposium focuses on the role of healthcare leaders in stimulating and implementing innovation in delivery within and across their organisations. We introduce a framework for identifying such innovations based on new research at London Business School. We also invite leading healthcare leaders and academics (from the Europe and the US) to discuss their own thoughts and experiences of introducing innovation in delivery.”

The conference is to be held on Friday 15 July 2011 at the Royal College of Obstetricians and Gynaecologists, 27 Sussex Place, Regent’s Park, London, NW1 4RG

The Cleveland Clinic is one of the most well-known and respected hospital groups in the US, with one of the largest cardiovascular and thoracic specialty departments in the world. The U.S. News & World Report has consistently ranked the Cleveland Clinic as the No.1 heart program in America every year since 1995. Located in Cleveland, Ohio, the Cleveland Clinic is a non-profit, multispecialty academic medical center that integrates clinical and hospital care with research and education. The Clinic has more than 1,400 beds on its main campus and 4,400 beds hospital-wide.

Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 35,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.